海正生材(688203) - 2025 Q4 - 年度业绩

Financial Performance - In 2025, the company achieved total operating revenue of 851.59 million yuan, a year-on-year increase of 0.76%[2] - Operating profit decreased by 64.48% to 17.17 million yuan, while total profit fell by 64.39% to 16.80 million yuan[4] - Net profit attributable to shareholders of the parent company was 9.21 million yuan, down 74.05% compared to the previous year[4] - The net profit after deducting non-recurring gains and losses was 7.10 million yuan, a decline of 77.25% year-on-year[4] - Basic earnings per share decreased by 72.22% to 0.05 yuan[6] Assets and Equity - Total assets at the end of the reporting period were 2,014.25 million yuan, a decrease of 2.49% from the beginning of the period[4] - Shareholders' equity attributable to the parent company was 1,476.44 million yuan, down 1.01% from the beginning of the period[4] Market and Financial Conditions - The decline in profits was primarily due to market competition leading to downward pressure on product sales prices, resulting in reduced gross margins[5] - Financial expenses increased due to a decrease in interest income and exchange gains, alongside rising depreciation and taxes from ongoing investment projects[5] - The financial data presented is preliminary and unaudited, with potential discrepancies in the final annual report[7]

ZHEJIANG HISUN BIOMATERIALS CO.LTD.-海正生材(688203) - 2025 Q4 - 年度业绩 - Reportify